Literature DB >> 6194312

Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

R M Iorio, M A Bratt.   

Abstract

Eighteen independent hybridomas producing monoclonal antibodies to Newcastle disease virus have been prepared by fusion of SP2 cells with spleen lymphocytes from a BALB/c mouse immunized with intact UV-inactivated Newcastle disease virus strain Australia-Victoria. They have been divided into three groups on the basis of radioimmunoprecipitation, infected cell surface and cytoplasmic fluorescence, and isotype. The anti-HN group is made up of nine antibodies which give surface fluorescence on infected cells and immunoprecipitate the HN glycoprotein. These antibodies bind to HN in nitrocellulose transfers of sodium dodecyl sulfate gels, but only if it has been neither reduced nor boiled. To varying degrees, all of these HN antibodies neutralize infectivity. These results suggest that they recognize exposed determinants of a conformational nature on the native HN molecule. They have been used in competition antibody-binding radioimmunoassays and additive neutralization assays, and on the basis of these studies the epitopes they recognize have been subdivided into four domains, two of which are overlapping, on the HN glycoprotein. The relatively weaker neutralizing activity observed with some of these antibodies cannot be explained by lower avidities for their epitopes because there is not an inverse correlation between estimated binding constant and neutralizing activity. The four antibodies in the second group all give a predominantly cytoplasmic fluorescence pattern, immunoprecipitate the nucleocapsid protein, and bind to nucleocapsid protein in nitrocellulose transfers of reduced and nonreduced sodium dodecyl sulfate-polyacrylamide gels. All five of the antibodies in the third group are of the immunoglobulin M class, unlike the others which are all immunoglobulin G antibodies. Members of this group show variable fluorescence patterns, but none is able to immunoprecipitate or bind to a specific viral antigen transferred to nitrocellulose paper from sodium dodecyl sulfate-polyacrylamide gels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194312      PMCID: PMC255369     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancois; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Molecular recognition and the future of monoclonal antibodies.

Authors:  D Lane; H Koprowski
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

6.  Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system.

Authors:  M B Oldstone; F J Dixon
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

7.  Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro.

Authors:  S R Weiss; M A Bratt
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

8.  Protein synthesis in Newcastle disease virus-infected chicken embryo cells.

Authors:  L E Hightower; M A Bratt
Journal:  J Virol       Date:  1974-04       Impact factor: 5.103

9.  Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation.

Authors:  T G Morrison; D Simpson
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

View more
  39 in total

1.  Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change.

Authors:  Jianrong Li; Vanessa R Melanson; Anne M Mirza; Ronald M Iorio
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.

Authors:  Vanessa R Melanson; Ronald M Iorio
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements.

Authors:  K Nishikawa; T Morishima; T Toyoda; T Miyadai; T Yokochi; T Yoshida; Y Nagai
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests.

Authors:  M Lipkind; E Shihmanter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.

Authors:  Sayantan Bose; Aarohi Zokarkar; Brett D Welch; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

9.  Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion.

Authors:  Jianrong Li; Edward Quinlan; Anne Mirza; Ronald M Iorio
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

Authors:  V Jestin; M Cherbonnel; M Morin; M Guittet; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.